Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

NCT01264822 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT01264822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01264822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Lead sponsor
Eisai Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
January 13, 2011
Completion date
November 17, 2016
Enrollment
108 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

gastric low-grade malt lymphoma with helicobacter pylori positive